Top Page
Delorean Corporation Ltd
(Sydney:DEL)
Delorean Corporation Ltd (DEL) vs. iShares MSCI Australia ETF (EWA)
Delorean Corporation Ltd Business Overview & Revenue Model
Delorean Corporation Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.83M | 19.83M | 27.88M | 19.25M | 39.33M | 27.88M |
| Gross Profit | -2.99M | -2.99M | 7.83M | -7.18M | -6.77M | -342.89K |
| EBITDA | -6.13M | -6.13M | 5.04M | -9.06M | -11.87M | -4.08M |
| Net Income | -6.55M | -6.55M | 4.77M | -10.02M | -10.89M | -3.21M |
Balance Sheet | ||||||
| Total Assets | 48.30M | 48.30M | 28.05M | 17.92M | 24.10M | 28.77M |
| Cash, Cash Equivalents and Short-Term Investments | 10.66M | 10.66M | 8.84M | 1.00M | 3.12M | 13.07M |
| Total Debt | 31.31M | 31.31M | 9.07M | 7.62M | 2.63M | 2.78M |
| Total Liabilities | 40.45M | 40.45M | 19.28M | 15.75M | 12.21M | 12.50M |
| Stockholders Equity | 7.85M | 7.85M | 8.77M | 2.17M | 11.88M | 16.27M |
Cash Flow | ||||||
| Free Cash Flow | -21.50M | -21.50M | 6.89M | -6.80M | -15.21M | -2.59M |
| Operating Cash Flow | -5.66M | -5.66M | 7.24M | -5.36M | -11.77M | 156.59K |
| Investing Cash Flow | -15.08M | -15.08M | -3.92M | -1.44M | -3.44M | -4.49M |
| Financing Cash Flow | 23.33M | 23.33M | 915.22K | 4.68M | 5.26M | 14.49M |
Delorean Corporation Ltd Technical Analysis
Delorean Corporation Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | AU$24.55M | 17.65 | 14.11% | ― | -11.85% | 6.25% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
49 Neutral | AU$34.25M | -13.13 | -11.34% | ― | -8.52% | 13.51% | |
45 Neutral | AU$20.09M | -5.70 | -38.32% | ― | 2.69% | -273.87% | |
42 Neutral | AU$24.78M | -2.75 | -129.44% | ― | -29.97% | -284.16% | |
42 Neutral | AU$11.53M | -2.56 | -47.12% | ― | ― | -15.24% | |
34 Underperform | AU$7.14M | -0.41 | -84.32% | ― | ― | 91.54% |
Delorean Corporation Ltd Corporate Events
Delorean Corporation has confirmed that its proposed Horsley Park Bioenergy plant in New South Wales will not proceed after partner Brickworks chose not to move toward a final investment decision on the jointly developed project. In response, Delorean plans to redirect its efforts to other project opportunities in NSW, advance its VIC1 project into construction, and continue progressing construction of its wholly owned SA1 facility, signalling a reallocation of capital and management focus that may reshape its development pipeline but underlines its broader commitment to expanding bioenergy capacity across multiple states.
The most recent analyst rating on (AU:DEL) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.
Delorean Corporation Limited, a company listed on the Australian Securities Exchange, held its Annual General Meeting on 28 November 2025 in West Perth, Western Australia. During the meeting, all resolutions were decided by a poll, and the outcomes were favorable, with all proposed resolutions being carried. This includes the adoption of the remuneration report, the re-election of directors, ratification of prior issue of options, approval of a 7.1A mandate, and the appointment of an auditor. These results indicate strong shareholder support for the company’s current management and strategic direction.
The most recent analyst rating on (AU:DEL) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.
Delorean Corporation Ltd presented at its Annual General Meeting, emphasizing its role in catalyzing Australia’s bioenergy sector. The presentation highlighted the company’s strategic focus on renewable energy and its potential impact on the industry, although it cautioned that the information provided was not a basis for investment decisions.
The most recent analyst rating on (AU:DEL) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.
Delorean Corporation Ltd has reached a significant milestone with the completion of its largest construction contract, the Lilydale bioenergy facility, and is progressing with its first fully-owned project in South Australia. The company is expanding its build/own/operate clean energy infrastructure, with projects in New South Wales and Victoria, and aims to generate diverse revenue streams from these assets. Delorean’s strategic collaboration with Paper Australia Pty Ltd highlights its commitment to expanding its portfolio, while maintaining a balanced financial strategy through debt management and grant funding.
The most recent analyst rating on (AU:DEL) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.
Delorean Corporation Limited has released its 2025 ESG report, emphasizing its commitment to Environmental, Social, and Governance (ESG) principles as a core component of its operations and success. The report outlines the company’s sustainability objectives, impact approach, and alignment with Australian and global sustainability standards. By integrating ESG strategies, Delorean aims to enhance its role in the global energy transition, benefiting stakeholders and reinforcing its market positioning.
Delorean Corporation Limited has made significant progress in its project portfolio for Q1 FY2026, achieving key milestones such as completing a $2.7 million ARENA milestone for the SA1 project and practical completion of the Yarra Valley Water project. The company has secured a $14.5 million loan from National Australia Bank to refinance existing debt and expand its Build-Own-Operate portfolio, alongside securing long-term revenue contracts for biomethane and liquid CO₂. Delorean is well-positioned to benefit from Australia’s increasing focus on renewable gas and decarbonization, supported by recent regulatory reforms and government initiatives.
Delorean Corporation Limited (ASX: DEL) has announced that its 2025 Annual General Meeting (AGM) will be held in person on November 28, 2025, in West Perth, Western Australia. Shareholders can access the Notice of Meeting and Explanatory Memorandum online, and are encouraged to lodge their proxy votes electronically. The company has provided detailed instructions for proxy voting and has made all relevant meeting materials available on its website and the ASX platform. This announcement underscores Delorean’s commitment to engaging with its shareholders and ensuring transparency in its corporate governance practices.
Delorean Corporation Limited has announced its upcoming Annual General Meeting (AGM) scheduled for November 28, 2025, in West Perth, Australia. The meeting will cover several key agenda items, including the review of financial statements, the adoption of the remuneration report, and the re-election of directors. Additionally, shareholders will consider the ratification of a prior issue of options. These resolutions are significant as they address corporate governance, executive compensation, and shareholder interests, potentially impacting the company’s strategic direction and stakeholder engagement.
Delorean Corporation Ltd has commenced the Operations & Maintenance phase at the Yarra Valley Water’s Lilydale Bioenergy Facility in Victoria, marking the completion of a $53 million construction project. This facility will process 55,000 tonnes of food waste annually, generating over 39,000 kWh of renewable electricity per day and reducing CO₂ emissions by approximately 24,700 tonnes annually. This project reinforces Delorean’s capability in delivering large-scale renewable energy infrastructure and contributes to its revenue base as it advances its first Build-Own-Operate facility in South Australia.
Delorean Corporation Ltd has announced the completion of construction for the Yarra Valley Water Lilydale bioenergy facility in Victoria. The facility, which processes 55,000 tonnes of organic waste annually, will generate renewable electricity and reduce CO₂ emissions significantly. The completion marks the start of the Operations & Maintenance phase, valued at $8 million over two and a half years, enhancing Delorean’s operational footprint in the renewable energy sector.
Delorean Corporation Ltd has successfully received a $2.7 million grant payment from the Australian Renewable Energy Agency (ARENA) as part of a $6.08 million funding agreement. This payment supports the development of Delorean’s SA1 Salisbury bioenergy facility in South Australia, which aims to produce mains-grade biomethane for industrial use. The project has achieved significant construction milestones, including the completion of tank farm slabs and the commencement of digester tank construction, keeping it on track to deliver renewable gas and long-term benefits to the South Australian industry.
Delorean Corporation Ltd has announced a reduction in profit due to delays in the grid connection of its Yarra Valley Water DBOM contract. Despite these delays, the company remains confident in the project’s financial success, as the contract’s operational and maintenance phases are expected to offset initial profit reductions. The company also confirmed compliance with ASX Listing Rules and highlighted that the financial impact was only finalized with the release of its Preliminary Final Report.
Delorean Corporation Limited has released its Annual Report for 2025, highlighting its focus on bioenergy and renewable energy sectors. The report outlines the company’s financial performance, strategic initiatives, and future outlook, emphasizing its commitment to sustainability and innovation in the energy industry.
Delorean Corporation Limited has announced adjustments to its financial statements for the year ending June 30, 2025, as reflected in its Annual Report. The adjustments include a decrease in revenue due to higher project costs, changes in depreciation and finance costs, and an increase in income tax expense due to the reversal of deferred tax assets. Additionally, there were changes in financial position, including a reclassification of borrowings and adjustments in contract liabilities and reserves. These changes highlight the company’s financial recalibrations and their implications for stakeholders.